D.L. Carlson Investment Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-18,143
Closed -$1.3M 130
2016
Q4
$1.3M Buy
18,143
+13,061
+257% +$971K 0.44% 86
2016
Q3
$402K Sell
5,082
-1,181
-19% -$95.9K 0.14% 106
2016
Q2
$522K Sell
6,263
-800
-11% -$71K 0.19% 101
2016
Q1
$649K Sell
7,063
-670
-9% -$60.4K 0.24% 93
2015
Q4
$783K Sell
7,733
-9,612
-55% -$1M 0.29% 93
2015
Q3
$1.7M Sell
17,345
-3,260
-16% -$362K 0.69% 64
2015
Q2
$2.41M Buy
20,605
+4,725
+30% +$516K 0.87% 45
2015
Q1
$1.56M Buy
15,880
+8,890
+127% +$903K 0.55% 75
2014
Q4
$659K Sell
6,990
-20,775
-75% -$2.15M 0.24% 107
2014
Q3
$2.96M Sell
27,765
-4,840
-15% -$474K 1.11% 34
2014
Q2
$2.7M Buy
32,605
+5,240
+19% +$408K 0.98% 42
2014
Q1
$1.94M Buy
+27,365
New +$2.15M 0.73% 61

Other funds holding GILD

D.L. Carlson Investment Group's GILD Position: Q1 2017 in Review

D.L. Carlson Investment Group sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 18,143 shares — an estimated $1.3M sold.

D.L. Carlson Investment Group first reported a position in GILD in Q1 2014 and held it in 12 quarters. The position peaked at $2.96M in Q3 2014. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • D.L. Carlson Investment Group reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 18,143 Gilead Sciences shares in Q1 2017, an estimated $1.3M.
  • D.L. Carlson Investment Group first reported a position in Gilead Sciences in Q1 2014 and held it in 12 quarters.
  • D.L. Carlson Investment Group's Gilead Sciences position peaked at $2.96M in Q3 2014.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on D.L. Carlson Investment Group's 13F filing for Q1 2017, filed 15 May 2017.